COVID-19 Response For Pharma Companies


During these unprecedented times, when COVID-19 has take over the world and the country is going under lockdown, it has become very tricky for all the industries to keep up with their businesses. In this article, we will discuss the impact of Coronavirus on Pharmaceutical companies and what actions they must take according to the experts.

There is always too much damage that has been made to pharmaceutical companies as lockdown has almost extended for more than two months now and most of the companies are shut, there’s a halt on import and export of services. The supply chain of these pharmaceutical companies is badly disrupted and no one knows for how long its going to stay with us.

Most of the active ingredients for pharmaceutical companies are imported from China and this pandemic has made country’s relationship a bit sore with China.

However, the industries will have to find ways to recover and thrive amidst and after the pandemic.

There are  a few key pointers through which pharma companies will be able to float through these difficult times.

Crisis Management Team

A crisis management team can be setup to bring out new policies and actions that can help in surviving the industry

Assign separate sub PMO leads for SCM, plant ops, people, IT, regulatory, finance, and industry.
  1. Define scenario planning, triggers for action, and responsibility/time lines for action
  2. Define communication plans for employees, customers, and vendors.
  3. Include key members from critical functions as a part of the crisis management team.
  4. Schedule meetings or calls among members of the crisis management team on a periodic basis to evaluate the current situation.
  5. Set up business continuity and recovery plans based on various scenarios.

People management


There is a greater risk of employing people who have been infected with COVID-19, which will increase the risk infection among other employees as well.

This is the reason, most of the companies have come with Work From Home policies. But, here are a few steps that companies can take once all of this is over.
  1. Set up a covid HR team to monitor the status of every employee in the organisation
  2. Launch a digital employee health declaration system to track employee well-being and comply with administrative reporting requirements. 
  3. Prepare a roster of employees operating in the plant on a rotation basis, keeping in mind risk assessment, location proximity, executive health reports, and annual checkup reports.
  4. Conduct a periodic medical checkup, including a thermal checkup/scanning at entry point for all employees.
  5. Educate employees on COVID-19 symptoms and prevention through video/audio conferences.

Supply Chain Management

Quality check of the products received (internal and external including) for any kind of contamination is going to be real challenge for the industry. There can also be the shortage of products as it is going to be one of the toughest challenges

  1. Stock critical inventory, connect with suppliers for key components
  2. Evaluate alternate sourcing for all affected materials such as availability of suppliers, additional cost due to logistics, etc.
  3. Avail the government’s financial incentive to those pharma companies ready to invest
  4. Understand inventory levels in the full supply chain, and adjust to new realities
  5. Sanitisation and thorough quality checks of all inbound material after quarantining them for a defined period of time
These are just a few measures that industries can undergo if they want to survive during and after the pandemic. Rest of it depends upon the leaders and owners of these companies and how swiftly they act on the current sitaution of pandemic.


Comments

Popular posts from this blog

How is AI used in risk management?

Impact of Digital Transformation on Banking Sectors in India

Deloitte’s Report on The eVTOL Evolution – Journey and Roadblocks Ahead